Skip to main content
Premium Trial:

Request an Annual Quote

Abbott Splits Company with AbbVie Spinout

NEW YORK (GenomeWeb News) – Abbott said today that it has completed the separation of its research-based pharmaceutical business, which has been spun out into a publicly traded entity called AbbVie.

Abbott announced its plans to split the company into two separate, publicly-traded companies — one focused on diversified medical products and the other on research-based pharmaceuticals — in October 2011.

In late November Abbott's board of directors declared a special dividend distribution of all outstanding shares of AbbVie stock. For every one share of Abbott common shares held, Abbott shareholders received one share of AbbVie common stock on Jan. 1.

Abbott said that it is now composed of four businesses — diagnostics, medical devices, nutritionals, and branded generic pharmaceuticals — all of roughly equal size.

Abbott Chairman and CEO Miles White said that the split is "the most transformative action" in Abbott's 125-year history.

In Wednesday morning trade on the New York Stock Exchange shares of Abbott were up 1 percent at $31.79.

The Scan

Study Finds Sorghum Genetic Loci Influencing Composition, Function of Human Gut Microbes

Focusing on microbes found in the human gut microbiome, researchers in Nature Communications identified 10 sorghum loci that appear to influence the microbial taxa or microbial metabolite features.

Treatment Costs May Not Coincide With R&D Investment, Study Suggests

Researchers in JAMA Network Open did not find an association between ultimate treatment costs and investments in a drug when they analyzed available data on 60 approved drugs.

Sleep-Related Variants Show Low Penetrance in Large Population Analysis

A limited number of variants had documented sleep effects in an investigation in PLOS Genetics of 10 genes with reported sleep ties in nearly 192,000 participants in four population studies.

Researchers Develop Polygenic Risk Scores for Dozens of Disease-Related Exposures

With genetic data from two large population cohorts and summary statistics from prior genome-wide association studies, researchers came up with 27 exposure polygenic risk scores in the American Journal of Human Genetics.